中国
质量(理念)
公共卫生
控制(管理)
业务
免疫
疾病控制
经济增长
医学
环境卫生
政治学
免疫学
经济
管理
认识论
哲学
护理部
抗原
法学
作者
Miao Xu,Zhenglun Liang,Yinghua Xu,Junzhi Wang
标识
DOI:10.1586/14760584.2015.1012503
摘要
Through the continuous efforts of several generations, China has become one of the few countries in the world that is capable of independently addressing all the requirements by the Expanded Program on Immunization. Regulatory science is applied to continuously improve the vaccine regulatory system. Passing the prequalification by WHO has allowed Chinese vaccine products to go global. Chinese vaccine products not only secure disease prevention and control domestically but also serve the needs for international public health. This article describes the history of Chinese vaccine development, the current situation of Chinese vaccine industry and its contribution to the prevention and control of infectious diseases. We also share our experience of national quality control and vaccine regulation during the past decades. China's experience in vaccine development and quality control can benefit other countries and regions worldwide, including the developing countries.
科研通智能强力驱动
Strongly Powered by AbleSci AI